Reference (Year) | ① | ② | ③ | ④ | ⑤ | ⑥ | ⑦ | ⑧ | ⑨ | ⑩ | ⑪ | Total score |
|---|
Chao 2014 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 |
Levi 2014 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
Chen 2015 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 9 |
Lai 2018 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 9 |
Moon 2020 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 |
- AHRQ: ① Whether the source of the data has been clarified (investigation, literature review);② Include and exclude criteria for both exposed and non exposed groups (case and control) or refer to previous publications;③ Whether a time period for identifying patients has been provided;④ If it is not a population source, whether the research object is continuous;⑤ Whether the subjective factors of the evaluator conceal other aspects of the research object;⑥ Describe any evaluation conducted to ensure quality (such as testing/retesting of primary outcome indicators);⑦ To explain the reasons for excluding any patients from the analysis;⑧ Describe how to evaluate (or control measures for confounding factors;⑨ Explained how to handle lost data in the analysis if possible;⑩ To summarize the response rate of patients and the completeness of data collection;⑪ To identify the percentage of expected patients with incomplete data or follow-up results if follow-up is available
